I feel that I have been a bit remiss in providing updates here on my blog, but I figure I have a good excuse – namely fatigue from my Sylatron treatment, as well as being more easily distracted by a myriad of things, perhaps again because of the treatment.

I gave myself my fourth Sylatron injection last Wednesday, marking the half-way point of the induction phase of my treatment. And while my side effects are not nearly as challenging as they could be (two of my melanoma buddies who just started their Sylatron have already experienced fevers and chills within a half day of their first injections), it’s a bit of work to overcome the side effects I do have.

Two side effects are most prevalent. Fatigue is the first, mostly taking place in the mid to late afternoon every day. The occasional nap seems to help, as does exercise in the form of long walks in and around the city. On days when I have client commitments I seem to be able to bull through the fatigue for the most part, but can’t keep that up for more than a day or two without taking a break (including naps).

The other side effect that I find perhaps more disturbing is a lack of appetite. I can eat, and I’m certainly not starving myself, but a lot of the joy I took from creating my own meals and puttering about in the kitchen seems to have dulled. Folks who know me know that food is a major passion, so to have that passion fade somewhat is emotionally distressing. Again, I can overcome it (like with the excellent home-made clam chowder I made on the 4th of July), but it takes quite a bit of effort to motivate myself. I am also able to dine out at nice restaurants, but the portions I consume are necessarily smaller than they used to be, and it takes a bit of work to get through a multi-course meal. The good news, in a way, is that I am very slowly approaching the weight I had before I was diagnosed with cancer back in March.

I have also found that the injection sites are a bit tender for the first week after an injection, and that bruising is not uncommon – both of these symptoms require that I change my injection site each week.

So far, I have had two blood tests to see how my body is reacting to the Sylatron, and these have shown a noticeable drop in my white blood cell and platelet counts, but not so low as to have me suspend treatment. I get another blood test next week along with a meeting with my oncologist to discuss my status and my upcoming radiation treatment.

One good bit of news I learned about the cost of my Sylatron treatment is that when I resume with the maintenance dose of 3μg/kg (the current induction dose is double that – 6μg/kg), the cost of the Sylatron each month will be almost half of the present $12,576.99. We are still waiting for the insurance company to even register the claim for the first month’s dose we submitted nearly four weeks ago, incidentally. Not very encouraging, although we did get a letter indicating they had precertified the drug.

Genetics

One of the things I had requested back in May was a genetic analysis of my cancer cells, in the hopes that should I have a relapse down the road, drugs which target specific genetic mutations will be available to treat my cancer. It takes about a month for the genetic testing, and I learned a couple of weeks ago that my particular genetic mutation occurs in the NRAS gene (more specifically, at Q61-182Am, with the Gln61Arg mutation).

According to one paper I have read, about 20% of all melanoma mutations are NRAS, but most of the gene-specific treatments being worked on right now are focused on mutations of the BRAF gene, which is more prevalent in melanoma. I hope, for entirely selfish reasons, that more work will be performed on NRAS mutations in the coming years, so that when I might need additional treatment, the appropriate drugs will be ready for me.

In Memoriam

The saddest and scariest thing to occur this past week was learning that Mark Beckelman had passed away as a result of his fight with melanoma. Mark was one of the leading Photoshop experts in the U.S., but more importantly, he had been an inspiration to me. I “met” Mark this past semester – he was my Photoshop for Photographers instructor at the Academy of Art University. When I expressed my concern to him this spring about not being able to complete my coursework in a timely manner due to my melanoma diagnosis, Mark volunteered that he knew my pain, intimately, as he too had gone through a similar diagnosis and subsequent surgeries back in 2006.

At a time when I knew no one else who had had melanoma and all statistics suggested it was a likely near-term death sentence, the exchanges I had with Mark gave me hope that I had at least a few more years ahead of me, at the very least. He also relayed that he had had a relapse last year and was still fighting the spread of his melanoma, and that things were not looking too good.

On July 5th, Mark succumbed to his melanoma.

Even while he was suffering from his advanced melanoma, he had time to help me come to grips with my own diagnosis. For that I will be forever grateful, and hope that I can be as strong and giving of myself as he was with me. And that doesn’t even cover what I learned from him technically.

Mark – Rest in peace, and thank you.

Lymphedema

The other situation I am dealing with is the aftermath of my lymphadenectomy (also known as a completion lymph node dissection). One of the common physical artifacts from that surgery is lymphedema, which is a swelling of the region near the place where the lymph nodes were removed due to the accumulation of lymph fluid (the fluid that drives the lymphatic system). The reason for this is that the removal of the lymph nodes ends up acting as a block or dam preventing the lymphatic fluid from taking the usual paths (which would previously have been through the lymph nodes, acting as filters).

To minimize the lymphedema I am experiencing I have to wear a compression stocking 24 hours a day on my right leg, plus exercise (walking works well for this) to keep to the lymph fluid from collecting in my leg. Additionally, I have weekly physical therapy sessions with a lymphedema therapist, who performs an hour-long lymphedema massage on me to move the pooled lymph fluid up around and past the blockage into my torso where the body can deal with it more appropriately. The therapist, Kathy, has also shown Linda how to perform the lymphedema massage, and my lovely wife has been patiently performing the massage each evening before I go to sleep, as the end of the day is when the lymph fluid pooling is at its worst (you can feel hard patches just under the skin where the fluid has accumulated).

I will mention that my lymphedema swelling has been gradually improving (getting less), to the point where the swelling in my leg is barely noticeable, but unfortunately it has not gone away entirely, and I will likely face wearing a compression stocking for the rest of my life.

One of the goals, though, is to reduce the regular swelling as much as possible before I start my radiation treatment next month, as the radiation treatment will exacerbate the existing scar tissue in my right groin, and thus lead to more blockage and therefore more lymphedema. So, the more my lymphedema can be dealt with before then, the less severe the results will be of the radiation treatment – or at least that’s the theory.

Labels

As my blog post today is a bit of potpourri, I wanted to share my thoughts on a subject that has been bugging for some time – namely labels for those with cancer, and in particular, at which point someone can be deemed to be a “cancer survivor”.

Based on my readings and conversations, I have come across four cancer classifications/terms which are applied to those with cancer:

• Cancer patient
• Cancer sufferer
• Cancer survivor
• Cancer victim

From the rather intimate perspective of someone who has been diagnosed with cancer, I find myself unsatisfied with these terms.

The term “cancer patient” is the only that perhaps best applies to me in my present situation, since I am still undergoing treatment (and will be for at least a year or more). This term is the only one that seems to have some practical relevance to what is actually going on in the life of a person undergoing cancer treatment.

“Cancer sufferer” by its very nature, suggests there is suffering involved. While the mental anguish of being diagnosed with cancer could perhaps be seen as a form of suffering, society’s use of the term suggests that the suffering should be that of physical discomfort. However, for many cancer patients, the physical suffering relates to the treatment of their cancer (such as surgery and chemotherapy), and not the cancer itself. As such, perhaps this term would be better cast as “cancer treatment sufferer”. I don’t mean to diminish the pain and anguish of people with cancer who are suffering from the actual cancer itself, but I believe that casual users of the term don’t necessarily understand the distinction between suffering from treatment and suffering from cancer.

One of my melanoma buddies recently referred to me in his missives as a “cancer survivor”, and while I appreciate the thought, I must say I do not think of myself as a cancer survivor, at least not yet. At present there is no way to know if any cancer cells remained in my body after surgery two months ago, but the probability is high that not everything was completely removed. Think of it this way – you pour fine grain salt from a height onto a smooth kitchen counter. The salt represents cancer cells. The surgery is like a large sweep of a hand and arm across that counter. What is the likelihood that a single grain of salt remains on the counter, perhaps in some corner or area where the sweeping hand didn’t come across it? If you’ve ever spent any time cleaning kitchen counters, you’ll know the probability is high that there will be at least one grain hiding out somewhere.

This is why people in my situation go through systemic cancer treatment (like I am doing with the Sylatron), and also through localized treatment (like I will be doing with my radiation treatment next month). And why I will be getting regular scans every three months for the first couple of years.

As a cancer patient, I can’t see myself labeled as a “cancer survivor” until I have hit some sort of threshold or milestone with no cancer relapse. Statistically, for at least melanoma, the most cited milestone appears to be the five-year mark, and thus, if I make it to March 2016 without a relapse of my melanoma, I will gladly start calling myself a cancer survivor at that time. Until then, I am a cancer patient (and hopefully nothing worse).

What could be worse? Being a “cancer victim”. That has a rather terminal feel to it, as it suggests that one has already succumbed to cancer. However, I have heard living cancer patients referred to as cancer victims, and I can’t imagine how painful it must be for a cancer patient or the patient’s family to have that very negative term used in relation to the living patient.

Protesting Cancer

As I have been learning over the last four months (and it seems somehow so much longer than that), cancer does not discriminate. We just don’t hear much about how prevalent cancer really is. A recent fund raising e-mail from the LIVESTRONG Foundation suggests that, based on a global survey, only 34 percent of people said they would tell their friends if they had cancer. That is truly scary.

I’m firmly of the belief that the best way to address cancer individually and as a society is to be open about it and help people realize that cancer affects us all – either via friends and family who have cancer, or when one is diagnosed with a cancer.

In that vein, I now regularly wear a t-shirt that says “Cancer Sucks” (I have five different ones), along with a black silicone wristband with the same phrase. Linda and Krystyana wear pins, necklaces, and bracelets that feature black cancer ribbons with the word “hope” to share their support. I should add that black is the color for melanoma, and that someone somewhere came up with a color coding for each major type of cancer (hence the pink ribbon for breast cancer – see http://www.choosehope.com/category/by-cancer-color-cancer-type for more examples).

The idea with the “Cancer Sucks” t-shirts, the jewelry, and the wristbands is to both increase awareness that cancer can affect us all as well as a start a conversation with others who want to express their frustration and angst regarding cancer, and show support for friends and family who have been diagnosed with cancer.

I have had dozens of strangers come up to me in the last couple of weeks to tell me that they agree with my shirt, and some even ask where I got my shirt from so they could get their own. In case you’re interested, that happens to be the web site Choose Hope (http://www.choosehope.com), which donates a part of its proceeds to cancer research.

On that note, let me leave you with a photo of my t-shirt, worn yesterday on Boston’s Beacon Hill:

One of my many new "Cancer Sucks" t-shirts

One of my many new "Cancer Sucks" t-shirts

 

While I wasn’t particularly concerned about the earth being ravaged by earthquakes yesterday as part of the widely publicized rapture, I did find myself relieved that nothing of earth shaking significance happened anywhere. I also find myself pitying the thousands of Rapture believers for whom reality contrasted sharply with their fervent beliefs and expectations in what was going to happen to them. It’s a lesson that those of us who have been diagnosed with cancer can learn from as well. And before you suggest I’m being negative, let me point out there’s a difference between hope and expectation. I hope and wish that I will live a long time. However I limit my expectations to the near-term, as that is all I can judge and evaluate.

Part of the reason for limiting expectations is that cancer in general is the result of a mutation, and this cellular mutation exists and adapts in a very Darwinian fashion. Much as we try to kill the cancer cells, the cancer cells are trying to survive. So, while surgery and treatments may eliminate virtually all of the cancer cells in a body, there’s no proven, consistent way across all patients, to completely eradicate all residual cancer cells in a patient. In some cases, it works out, but the statistics and probability of complete “cure” vs. almost guaranteed relapse vary based on the type of cancer involved. According to “The Biology and Treatment of Cancer”, there are around 200 different kinds of cancer cells identified so far, with most unique enough to require targeted treatment. And it’s not uncommon for cancer cells to mutate further during some chemotherapy treatments and become resistant or immune to those treatments, requiring a new one to be applied or even developed (from “The Emperor of All Maladies”).

I understand from friends who have and have had cancer, as well as from my readings, that the stress and anxiety that surrounds the regular scans they have to see if their cancer has returned is high, because, of course, it could signal having to go through a whole new round of procedures with an uncertain outcome. And for better or worse, after my upcoming treatments are complete, I too will be victim to a (hopefully long) life of uncertainty, especially as my form of melanoma, which I’ve been told is “nodular melanoma” – a very aggressive form, evidenced by the progression from nothing to multiple tumors as large as 2.2cm in my lymph nodes in just four months, is known for a not-insignificant rate of recurrence. Statistically, because I also had cancer cells appear outside the capsule of a lymph node (i.e. extracapsular extension), that also increases the likelihood that I will be revisited by melanoma at some point in the future.

A new friend, who was diagnosed with melanoma about five years ago, but has recently had a relapse with complications, explained to me that he and his wife found that the best way to cope with the impact of the disease on the mind, soul, and body was to live in the moment, and live one’s life – something which he says is not always easy when you are dealing with your own mortality. My piece on priorities a week ago kind of brushed on this idea, but I’m still coming to grips with the idea that I perhaps should not be making substantial long term (multi-year) commitments, which is causing me to reevaluate whether or not I want to continue pursuing my Master of Fine Arts in Photography degree (which will take another 3-4 years of time, nearly full time), or simply charge forth and spend that time in a more intensely productively fashion.

So, my future is a perpetual work in progress, taken a day or a week at a time.

The Fog of Cancer Therapy

In order to be true to the title of this post, namely the various “Fogs” I am experiencing, I would like to share both updates and current perspectives.

Last week I had my first meeting with the clinical oncologist under whose guidance I will be receiving my post-surgical cancer therapy. As I discussed previously, the purpose of the surgical lymphadenectomy (also referred to as a “complete lymph node dissection”) I had two weeks ago was to try and surgically remove the cancer from my lymphatic system before it could spread further, or more realistically, as much of it as possible. Cancer is insidious because it is a cellular mutation, meaning that if even one cancer cell (which is a very tiny, microscopic entity indeed) is left behind, over time it can multiply and spread. Using a macro-level procedure like surgery, while potentially good at removing larger aggregations of cancer cells (usually in the form of tumors), is not great at the cellular level for the simple reason that a surgeon can’t see and distinguish such cells.

That’s where adjuvant therapy comes into play. After surgery is over, additional steps are taking to try and destroy any vestiges of cancer that may still be present. There are two type of post-surgical treatment to be considered – localized and systemic.

In the case of my melanoma, the clinical oncologist suggested that both localized and systemic treatment be applied. The localized treatment would be via radiation, specifically in the area where my lymphadenectomy took place, namely my right groin region. The systemic treatment involves drugs which would be applied regularly to fight any cancer cells that might be left anywhere in my body – in the whole system (hence “systemic”).

The clinical oncologist discussed a number of options with me, including the stock treatment for stage III melanoma patients, namely Interferon-α, a new form of Interferon-α recently approved by the FDA called Sylatron, a late stage drug also recently FDA approved called Yervoy (ipilimumab), and some other experimental options via clinical trials.

Yervoy has the issue that it has not had any studies done yet for Stage III melanoma patients – only late state, Stage IV (for which it was successful as these things go). That meant that, considering the roughly $130,000 price tag for a four-course treatment of Yervoy, insurance would not cover the cost, nor was there necessarily any reason to believe it would even have any effect on Stage III melanoma – it might, but it also might not. The doctor mentioned that there was a clinical trial under way now for Yervoy in Stage III melanoma patients, but that it was a placebo-based trial (meaning that some participants would receive Yervoy, and the others placebos), and the results wouldn’t be known for years (since in Stage III there are no tumors to measure to determine effectiveness – it would be solely based on relapse timelines). Furthermore, Yervoy has potentially serious side effects, including liver disease and even (in very rare cases), death.

My wife Linda and I had discussed the possibility of clinical trials previously – which are basically where someone volunteers to be a subject in an experiment in the hopes the experiment is successful in producing a positive result, as compared to some sort of baseline. That baseline can either be a group of patients in the trial using an established treatment, or alternately, being given a placebo but being told it is the experimental drug. I have a tough enough time leaving things to chance, so the idea of being part of a clinical trial where there was a chance I would get a placebo and no treatment just was not for me (never mind that Linda would have vetoed any such participation as well because of the uncertainty).

Seeing as the Yervoy and other clinical trials currently available were placebo referenced, that ruled those out as options.

I had already known from my research that Interferon, which has been a standard Stage III melanoma treatment for over a decade, would be the most likely option for me, even though its side effects, while not generally harmful, are pretty miserable. Interferon works by boosting the immune system, with the hopes the immune system will then be better able to eradicate melanoma cancer cells on its own.

For many Interferon patients, the primary side effects are fatigue and flu-like symptoms – worse during the initial month of daily 90 minute long IV infusions of the drug, and a bit better during the subsequent 11 months of thrice-weekly self-injections. I’ve learned that it’s not uncommon, due to the impact of these symptoms for people to end their treatment early because they just cannot stand the physical burden any longer. Regular Interferon, because it is in effect a naturally produced protein, is rapidly absorbed in the body, with all traces gone shortly after infusion. So the body has this big spike of Interferon at the time of injection or infusion, and then spends time trying to get back into equilibrium until the next application – so large peaks and troughs.

The recent approval and release of Sylatron appears to provide a more manageable solution to Interferon side effects. Sylatron is still the same type of Interferon as the traditional treatment, but encapsulated in such a way that it hangs out in the body for a much longer time. In very simple terms, you could look at it as similar to getting your aspirin or acetaminophen in a time-release form. This means that the extreme peaks and troughs are no longer present, and the body can better adjust to the sustained use of the Interferon. The flu-like symptoms and fatigue are still there, but not as intense in most people.

Also, because of the persistence of the pegylated Interferon, the dosage and application is less intense as well. Sylatron is applied weekly, and during the first two months, a higher dose is used, after which a lower stable dose is switched to. All of these can also be self administered. The trial in Europe in which Sylatron was used was intended to be a five year treatment, but the average time patients continued with the Sylatron injections was around 14-16 months apparently, but with long term relapse rates which appear to be better (lower) that traditional Interferon, with the added benefit that people were not as sick and, in fact, were able to live mostly normal lives during treatment.

The end result of the first consultation with the doctor was to confirm (as I had previously hoped) that my best course of treatment would be to go with Sylatron as my systemic treatment.

Assuming my insurance company doesn’t set up any roadblocks, I should be able to start my adjuvant therapy in early June after my (damn) drain has been removed, and all my healing from surgery looks good. My next appointment is at the end of the month to try and narrow things down further.

The Fog of Radiation

So, with Sylatron as my systemic treatment determined, the next thing to deal with was my radiation therapy. There has been some literature which has suggested that radiation therapy is not particularly effective for melanoma, but on the flip side, it has also not been shown to be ineffective. What I was advised was that in situations where there was a fair chance of residual cancer cells, such as my extracapsular extension and activity, radiation therapy’s benefits outweighed the risks.

When you’re faced with the potential of relapse at some point down the road, you definitely find yourself more inclined to do anything you can which has a decent chance of postponing when that point will be, and thus I found myself quite willing to go ahead with the treatment.

After a consultation on Friday with the radiologist (who specializes in oncological treatment via radiation), I feel pretty good about the process.

First, let me detail the side effects of localized radiation in my right groin region:

  • It will likely cause sterility, preventing me from fathering any more children. Not a worry – I’m quite happy with the two I have fathered naturally (Krystyana and Sebastian), and my two “adopted” children, Aisha and Chip.
  • During treatment it will cause a light burn and sensitivity on the skin’s surface in the irradiated region. This can be treated with creams.
  • I may permanently lose some pubic hair. May look strange, but other than nurses, doctors, and my wife, and myself, no one is likely to see that, and if they do, it would create an interesting point of discussion.
  • I may end up with darker skin in the same area as treatment. Hmm. Let me think – skin discoloration or leaving cancer cells behind in my body to grow and wreak more havoc? Yeah. I’ll go with skin discoloration.
  • May increase incidence of lymphedema – swelling in my leg due to excess accrual of lymphatic liquids. This can be a real hassle, but the doctor pointed out that there are trained massage therapists who specialized in lymphedema therapy, and the use of compression stockings (I’m wearing one now) can mitigate the problem somewhat. I can certainly work with regular massages (although Linda had to ruin the warm and fuzziness of massages by pointing out that they could be painful, like a deep tissue massage can be).
  • Could undue any healing that is still going on. This is a real potential problem, but with a practical solution, namely not starting my radiation therapy until later in the summer.

Ultimately, the decision that both doctors seemed to agree on (with my concurrence) was to have me start on the Sylatron treatment for the initial two months of high dose injections, then get baseline and diagnostic scans performed, dry out from Sylatron for a couple of weeks, and then start my radiation therapy. The therapy will involve 4-6 weeks of daily (weekday) 20 minute radiation treatments at Mass General Hospital, meaning I would be tied to being in Boston during that time – no travel possible so that I wouldn’t miss any treatments.

During the initial set up in preparation for my treatments, the radiology department would create a special mold for me to lie on for best exposure to the radiation source and then create a 3-D mapping of the region to be irradiated. And I get some tattoos on my body as an added bonus. The tattoos will be used as orientation and reference points for the radiation treatment to ensure that radiation positioning is exact.

The radiation treatment would be performed via Intensity-Modulated Radiation Therapy (IMRT), which is a very modern computer-controlled radiation delivery system which can control the intensity and angle of the radiation in a way to ensure the target area is getting all that it is supposed to while minimizing the amount of radiation in surrounding tissues and organs. I was also amazed to learn that the IMRT mapping involves Voxels – volumetric pixels (something some of my fellow graphics geeks may be familiar with), as a way to represent the radiation values and accumulation in a three dimensional space (a little more on this can be found here). Very cool technology.

The Fog of Frustration and Pain Medication

So now, here I sit, under a fog of frustration and pain medicine as I wait for my body to heal. I’ve figured out that I’ve been something of an invalid in terms of mobility for most of the last seven weeks, and I am sick and tired of it.

I’m used to doing things for myself, and it’s difficult for me to ask others to do otherwise simple things for me because I can’t without hurting myself in the process. Stupid things, like putting on socks, for example.

I also hate not being able to go out without causing myself grief. I had to miss a recently departed friend’s Celebration of Life yesterday, and would have loved to have gone out for dim sum in Boston’s Chinatown this morning. But no go with my current infirmity. I had hopes to get to New York City next weekend to see a friend perform at Carnegie Hall, but I’m guessing that’s not going to happen for me either. Very frustrating! It’s like being in a virtual jail – no tangible bars, but restrictive nonetheless.

The healing of my surgical area and graft site are progressing well enough, but I have a lot of pain and discomfort from swelling and from the area where the drain tube exits my body, and as a result have been on doctor-prescribed rest and pain medication. Add to that that I have to sleep on my back (because of the drain) on a bed that feels too soft, and the result is back pain (goes away when I get up) and not more than about six hours of fitful sleep during the night. I may well start having to nap during the day to catch up, a practice I never really adopted. Now may be the time.

The other frustration is that until my drain is removed, I cannot start my Sylatron treatment, and my drain won’t get removed until the amount coming out is less than 30cc per day (I’m at around 200cc right now, down from close to 500cc a week ago, so some progress is being made). And until I start my Sylatron treatment, I won’t have a clear idea of when my radiation treatments might start (although the best guess is mid-August or so).

Fortunately, while not being mobile, I am able to sit in my comfy office chair for decent periods of time, and work on my computer and some consulting client commitments as well.

And I can slowly shuffle around my kitchen for short periods of time, which resulted in a suitable substitute for my dim sum cravings this morning, crispy pork belly with compote of cranberries and cherries, depicted below:

Crispy pork belly with a cherry and cranberry compote

Crispy pork belly with a cherry and cranberry compote

The one thing, however, above all others that helps me overcome my frustration with being infirm is the support of my family, especially Linda, without whom I would not be able to manage at all, and without whom I would be an absolutely nut job now (or, as my kids might suggest, more of a nut job).

The Fog of Future Treatments

Okay, so may this isn’t a fog, really, but one of the things that has become known about cancers is that they occur because of gene mutations in the chromosomes of damaged cells. The most successful cancer treatments so far, across all cancers, have been ones that target specific mutations that exist in the cancer cells but no other normal cells in the body.

In melanoma treatment, there’s been a pretty amazing amount of work in such mutation specific research in just the least half-decade or so, the result being that there are a number of new treatments under development to address the various mutations (a great, but highly technical paper on this subject by several authors, including my own oncologist, can be found here).

What this means is that if the genetic mutation of the cancer is known, and that mutation is one for which a treatment is being developed (and tested), the greater the likelihood of effective treatment. And such targeted treatments are also potentially likely to have fewer side effects because they don’t have a systemic impact on anything other than affected cells.

In my case, just over a week ago, I had requested that cancer cells from my recent lymphadenectomy be genetically typed by the hospital’s lab. That process will take up to a month. The results won’t make a difference in my current treatment plan as the only clinical trials being done on mutation-specific drugs are only for late stage melanoma patients.

However, the really good thing about getting my cancer classified now is that if I do have a relapse some years down the road, it will vastly speed the decision on how to treat the relapse. With the speed and breadth of melanoma research at present, the likelihood is very high that there will be a number of targeted treatments available – even three or four years from now – that would help me fight a relapse, should that occur (although the hope is that won’t be the case).

In Conclusion: The Fog of Boston

Keeping with my fog theme, I would like to close by saying that the fog we have witnessed from our 37th floor apartment (36th actually, as there is no numbered 13th floor in the building) here in Boston has been spectacular this last week, with visibility so low at times that we could not see the street below us or the lights of the nearby Zakim bridge outside our windows. Back on Bonaire, the weather is never really cool enough to create fog, so this has been a remarkable climate contrast for us.

Not sure when my next post will be, but I’m guessing it will be after my doctors appointments on May 31st with an update on what’s going on with healing, drains, and treatment. Until then, please hang in there – that’s what I’ll be doing too.